OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) Ablation
NCT ID: NCT02204566
Last Updated: 2019-11-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2013-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As they swallow the capsule, images of the esophagus will be taken to see if the RF ablation caused any form of damage to the esophagus considering it being so close to the heart.
After the capsule has been removed from the mouth, they will be asked about the tolerability of the capsule.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Oesophageal Protection During AF Ablation
NCT03819946
Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation
NCT00650728
Atrial Fibrillation Ablation on Gastric Motility "The AF Gut Study"
NCT01396356
Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY
NCT04659213
Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation
NCT00584922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As the capsule progresses down the esophagus, multiple, two dimensional, microscopic cross- sectional images of the esophagus are acquired.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OFDI Capsule Imaging
Subject will swallow the OFDI capsule and imaging will be acquired using the OFDI Imaging system.
OFDI Capsule
Imaging of the esophagus using the OFDI Capsule and system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OFDI Capsule
Imaging of the esophagus using the OFDI Capsule and system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be able to give informed consent.
* Subjects must be referred to Massachusetts General Hospital (MGH) endoscopy for RF Ablation treatment of their Atrial Fibrillation.
Exclusion Criteria
* OR subjects with a prior history of intestinal strictures, prior GI surgery or intestinal Crohn's disease.
* OR subjects with a known history of chronic aspiration.
* OR women who are currently pregnant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guillermo Tearney
Professor of Pathology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo Tearney, MD., PhD
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-P-001952
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.